go-v.orgdoi

Digital Biomarkers in Psychiatry: The Role of Smartphones, Wearable Devices, and Artificial Intelligence in Mental Health Care

Karolina Solka, Anita Godlewska Barys Aliaksandrau, Anna Kocik Rafał Knowa, Monika Łapot, Bartłomiej Wiak Yuliia Dehtiarova, Wiktoria Raczek, Agata Wywiał Anastasiya Shamryla, Klaudia Spaczyńska Justyna Ostasiewicz, Anna Kropiwnicka Aleksandra Luiza Pasternak, Ernest Racki Alina Shamryla, Yassine Motaouakkil Yuliya Hlukhava, Bartosz Mikołajek Wiktoria Bartkowiak, Mateusz Czarnacki Karolina Popławska, Emilia Włoszek, Robert Kozłowski Marfa Malinouskaya, Lilianna Świder, Aleksandra Miszel, Stanislaw Gattner, Ewa Fudalej, Aleksandra Molek · African Journal of Biomedical Research · 2026

  • DOI 10.69980/3
  • Publisher African Journals OnLine
  • Type article
  • Issued 2026

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

African Journal of Biomedical Research · African Journals OnLine · article · 2026

Abstract

Background: Traditional psychiatric assessment relies heavily on self-report and may not reflect patients’ functioning between clinical visits. Digital biomarkers and phenotyping offer objective, continuous measures of everyday behavior and physiology. Methods: This narrative review evaluated research on smartphone sensing, wearable devices, and AI-based psychiatric monitoring, focusing on clinical value, measurement validity, implementation challenges, and ethical safeguards. Results: Smartphones and wearables can monitor mobility, sleep, activity, communication, device use, heart rate, and other physiological signals.

Machine-learning models may detect changes in symptoms, treatment response, and relapse risk, particularly in depression, bipolar disorder, and schizophrenia. However, current evidence is limited by small samples, short follow-up, device variability, missing data, limited external validation, algorithmic bias, false alerts, and privacy concerns. Conclusion: Digital biomarkers may enable more continuous and personalized psychiatric care but cannot replace clinical assessment. Safe implementation requires validated and interpretable models, secure data governance, equitable access, clear response protocols, and ongoing clinician oversight.

Open the resolved locator · 10.69980/3

Metadata licence: OpenAlex metadata (CC0)